Apogee Therapeutics Logo

Apogee Therapeutics

🇺🇸
APGE
US03770N1019

Apogee Therapeutics is a leading U.S. biotechnology company specializing in the development of advanced biologic therapies for immunological and inflammatory diseases. Through innovative protein engineering technologies, the company targets and addresses key drivers of inflammatory processes.

Next Quarterly Earnings

Monday, November 16, 2026
CW 47
Pre-Market
In 81 days

Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

Quiet period starts on October 19, 2026

Stock Price

Frequently asked questions

When will Apogee Therapeutics report its next quarterly earnings?

Apogee Therapeutics is scheduled to report its next quarterly earnings on 11/16/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

When did Apogee Therapeutics last report quarterly earnings?

Apogee Therapeutics last reported quarterly earnings on 8/10/2026 (Q2 2026). Earnings per share (EPS) came in at -1.14 USD.

How often has Apogee Therapeutics beaten expectations?

Apogee Therapeutics has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).

How do I add the Apogee Therapeutics earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$1.15
Actual:
Q2 2026
Missed
Estimate:-$1.07
Actual:-$1.14
Difference:-$0.07
Q1 2026
Beat
Estimate:-$1.07
Actual:-$1.06
Difference:+$0.01
Price reaction (1 day):+1.9 %
Price reaction (7 days):-5.2 %
Q4 2025
Beat
Estimate:-$1.04
Actual:-$1.03
Difference:+$0.01
Price reaction (1 day):+1.3 %
Price reaction (7 days):+7.1 %
Q2 2025
Beat
Estimate:-$1.15
Actual:-$1.11
Difference:+$0.04
Q1 2025
Missed
Estimate:-$1.05
Actual:-$1.13
Difference:-$0.08

Earnings statistics

Estimates vs. results

3/5
Quarters above estimates
60%
Beat rate
-0.9%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Apogee Therapeutics
Ticker Symbol
APGE
ISIN
US03770N1019
Country
🇺🇸
USA
Sector